Medicine.
Psychology, University of Washington, Seattle, WA.
J Acquir Immune Defic Syndr. 2018 Jul 1;78(3):276-282. doi: 10.1097/QAI.0000000000001680.
Little is known about fertility desire in HIV-positive female sex workers. Fertility desire could increase HIV transmission risk if it was associated with condomless sex or lower adherence to antiretroviral therapy.
A prospective cohort study was conducted among 255 HIV-positive female sex workers in Mombasa, Kenya. Using generalized estimating equations, fertility desire was evaluated as a risk factor for semen detection in vaginal secretions by prostate-specific antigen (PSA) test, a biomarker of condomless sex, detectable plasma viral load (VL), and HIV transmission potential, defined as visits with positive PSA and detectable VL.
The effect of fertility desire on PSA detection varied significantly by nonbarrier contraception use (P-interaction < 0.01). At visits when women reported not using nonbarrier contraception, fertility desire was associated with higher risk of semen detection [82/385, 21.3% vs. 158/1007, 15.7%; adjusted relative risk (aRR) 1.58, 95% confidence interval (CI): 1.12 to 2.23]. However, when women used nonbarrier contraception, fertility desire was associated with lower risk of PSA detection (10/77, 13.0% vs. 121/536, 22.6%; aRR 0.58, 95% CI: 0.35 to 0.94). Fertility desire was not associated with detectable VL (31/219, 14.2% vs. 128/776, 16.5%; aRR 0.82, 95% CI: 0.46 to 1.45) or higher absolute risk of transmission potential (10/218, 4.6% vs. 21/769, 2.7%; adjusted risk difference = 0.011, 95% CI -0.031 to 0.050).
Fertility desire was associated with higher risk of biological evidence of semen exposure when women were not using nonbarrier contraceptives. Low HIV transmission potential regardless of fertility desire suggests that the combination of condoms and antiretroviral therapy adherence was effective.
人们对 HIV 阳性女性性工作者的生育意愿知之甚少。如果生育意愿与无保护性行为或抗逆转录病毒治疗依从性降低相关,那么它可能会增加 HIV 传播的风险。
在肯尼亚蒙巴萨的 255 名 HIV 阳性女性性工作者中进行了一项前瞻性队列研究。使用广义估计方程,将生育意愿评估为前列腺特异性抗原(PSA)检测中阴道分泌物中精液检测的风险因素,PSA 检测是无保护性行为和可检测血浆病毒载量(VL)的生物标志物,可检测 VL 与 HIV 传播潜力定义为 PSA 和可检测 VL 阳性的就诊。
生育意愿对 PSA 检测的影响因非屏障避孕措施的使用而有显著差异(P 交互作用<0.01)。在女性报告未使用非屏障避孕措施的就诊时,生育意愿与精液检测的风险增加相关[82/385,21.3%vs.158/1007,15.7%;调整后的相对风险(aRR)1.58,95%置信区间(CI):1.12 至 2.23]。然而,当女性使用非屏障避孕措施时,生育意愿与 PSA 检测的风险降低相关(10/77,13.0%vs.121/536,22.6%;aRR 0.58,95%CI:0.35 至 0.94)。生育意愿与可检测 VL 无关(31/219,14.2%vs.128/776,16.5%;aRR 0.82,95%CI:0.46 至 1.45)或更高的绝对传播潜力(10/218,4.6%vs.21/769,2.7%;调整后的风险差异=0.011,95%CI-0.031 至 0.050)。
当女性未使用非屏障避孕措施时,生育意愿与精液暴露的生物学证据风险增加相关。无论生育意愿如何,HIV 传播潜力均较低,这表明避孕套和抗逆转录病毒治疗依从性的结合是有效的。